Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.

Arachidonic acid (AA; C20∶4 n-6) and docosahexaenoic acid (DHA; C22∶6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in...

Full description

Bibliographic Details
Main Authors: Jin-Ping Zhao, Emile Levy, William D Fraser, Pierre Julien, Edgard Delvin, Alain Montoudis, Schohraya Spahis, Carole Garofalo, Anne Monique Nuyt, Zhong-Cheng Luo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3890289?pdf=render
_version_ 1818493378868805632
author Jin-Ping Zhao
Emile Levy
William D Fraser
Pierre Julien
Edgard Delvin
Alain Montoudis
Schohraya Spahis
Carole Garofalo
Anne Monique Nuyt
Zhong-Cheng Luo
author_facet Jin-Ping Zhao
Emile Levy
William D Fraser
Pierre Julien
Edgard Delvin
Alain Montoudis
Schohraya Spahis
Carole Garofalo
Anne Monique Nuyt
Zhong-Cheng Luo
author_sort Jin-Ping Zhao
collection DOAJ
description Arachidonic acid (AA; C20∶4 n-6) and docosahexaenoic acid (DHA; C22∶6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming" this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies.In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. non-diabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = -0.37, P <0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18∶0 and C20∶0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity.Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming" the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.
first_indexed 2024-12-10T17:54:22Z
format Article
id doaj.art-202783ccbda6449398f06ed556247ce5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T17:54:22Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-202783ccbda6449398f06ed556247ce52022-12-22T01:38:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8505410.1371/journal.pone.0085054Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.Jin-Ping ZhaoEmile LevyWilliam D FraserPierre JulienEdgard DelvinAlain MontoudisSchohraya SpahisCarole GarofaloAnne Monique NuytZhong-Cheng LuoArachidonic acid (AA; C20∶4 n-6) and docosahexaenoic acid (DHA; C22∶6 n-3) are important long-chain polyunsaturated fatty acids (LC-PUFA) in maintaining pancreatic beta-cell structure and function. Newborns of gestational diabetic mothers are more susceptible to the development of type 2 diabetes in adulthood. It is not known whether low circulating AA or DHA is involved in perinatally "programming" this susceptibility. This study aimed to assess whether circulating concentrations of AA, DHA and other fatty acids are associated with fetal insulin sensitivity or beta-cell function, and whether low circulating concentrations of AA or DHA are involved in compromised fetal insulin sensitivity in gestational diabetic pregnancies.In a prospective singleton pregnancy cohort, maternal (32-35 weeks gestation) and cord plasma fatty acids were assessed in relation to surrogate indicators of fetal insulin sensitivity (cord plasma glucose-to-insulin ratio, proinsulin concentration) and beta-cell function (proinsulin-to-insulin ratio) in 108 mother-newborn pairs. Cord plasma DHA levels (in percentage of total fatty acids) were lower comparing newborns of gestational diabetic (n = 24) vs. non-diabetic pregnancies (2.9% vs. 3.5%, P = 0.01). Adjusting for gestational age at blood sampling, lower cord plasma DHA levels were associated with lower fetal insulin sensitivity (lower glucose-to-insulin ratio, r = 0.20, P = 0.036; higher proinsulin concentration, r = -0.37, P <0.0001). The associations remained after adjustment for maternal and newborn characteristics. Cord plasma saturated fatty acids C18∶0 and C20∶0 were negatively correlated with fetal insulin sensitivity, but their levels were not different between gestational diabetic and non-diabetic pregnancies. Cord plasma AA levels were not correlated with fetal insulin sensitivity.Low circulating DHA levels are associated with compromised fetal insulin sensitivity, and may be involved in perinatally "programming" the susceptibility to type 2 diabetes in the offspring of gestational diabetic mothers.http://europepmc.org/articles/PMC3890289?pdf=render
spellingShingle Jin-Ping Zhao
Emile Levy
William D Fraser
Pierre Julien
Edgard Delvin
Alain Montoudis
Schohraya Spahis
Carole Garofalo
Anne Monique Nuyt
Zhong-Cheng Luo
Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
PLoS ONE
title Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
title_full Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
title_fullStr Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
title_full_unstemmed Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
title_short Circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity.
title_sort circulating docosahexaenoic acid levels are associated with fetal insulin sensitivity
url http://europepmc.org/articles/PMC3890289?pdf=render
work_keys_str_mv AT jinpingzhao circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT emilelevy circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT williamdfraser circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT pierrejulien circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT edgarddelvin circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT alainmontoudis circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT schohrayaspahis circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT carolegarofalo circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT annemoniquenuyt circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity
AT zhongchengluo circulatingdocosahexaenoicacidlevelsareassociatedwithfetalinsulinsensitivity